NLRP3 and Alzheimer disease: Hyperactivation of the NLRP3 inflammasome has also been proven to inhibit the phagocytosis of amyloid-β by microglia, and exacerbate amyloid-β deposition and tau pathology, which accelerate the initiation and development of AD pathology [205, 206].